Answers are grounded in this paper and cite their sources.
The role of quercetin in AD appears to be multifaceted, and it can affect patients' frontal cortex in a variety of pathways, such as axonogenesis, immune infiltration, and glial cell differentiation. DYRK1A, NOS2, and NQO1 might be potential novel effective drug targets for quercetin in AD.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: